Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2007
09/19/2007CN100337637C Naevus removing ointment
09/19/2007CN100337634C Dropping pill of pueraria flavone and its preparing process
09/19/2007CN100337633C Rhodiola root glycosides injection for treating cardiovascular/cerebrovascular diseases and preparation method thereof
09/19/2007CN100337631C Fluorouracil injecting emulsion and production thereof
09/19/2007CN100337630C Palatable oral suspension and method
09/19/2007CN100337629C Milrinone sodium chloride injection and production thereof
09/19/2007CN100337628C Nimodipine oral disintegrant tablet for curing dementia and its preparation method
09/19/2007CN100337627C Berberine hydrochloride dispensing tablet and its preparing method
09/19/2007CN100337625C Anastrozole dispersed tablet formulation
09/19/2007CN100337622C Solid dispersion containing fumaric acid tiamulin and its preparation method
09/19/2007CN100337620C Water-soluble composition containing coenzyme q10
09/19/2007CN100337619C Ginseng-monkshood slow-release microporous for treating qi asthenia and yang depletion and preparing method thereof
09/19/2007CN100337618C Ginseng-monkshood slow-release coating film controlled tablet for treating qi asthenia and yang depletion and preparing method thereof
09/19/2007CN100337617C Gineng-monkshood skeleton slow-releae insoluble skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof
09/19/2007CN100337616C Ginseng-monkshood skeleton slow-release endo gastric detention tablet for treating qi asthenia and yang depletion and preparing method thereof
09/19/2007CN100337615C Oral disintegration tablet prepared from general saponin of notoginseng for treating thrombosis, and preparing technique
09/19/2007CN100337614C Medicinal aerosol formulation
09/19/2007CN100337613C Effervescence particles and preparing method thereof
09/19/2007CN100337549C Prebiotic and probiotic compositions and method for use in gut-based therapies
09/19/2007CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals
09/18/2007USRE39847 Method of treating a systemic disease
09/18/2007US7271234 Biocompatible polyarylates of tyrosine-derived diphenol compounds and poly(alkylene oxide) dicarboxylic acids, for use in injectable formulation and implantable articles for drug delivery and tissue engineering made from these polymers
09/18/2007US7271156 Immunostimulatory nucleic acids
09/18/2007US7270881 Hydrogel forming thermoplastic elastomers; Synthetic or natural rubbers; copolymers and block copolymers of ethylene; vinyl polymers; polyurethanes, polyethers, polydimethylsiloxane, proteins or mixtures; disposable products; diapers; absorbers
09/18/2007US7270838 Composition for treating chronic venous insufficiencies using an extract of red vine leaves
09/18/2007US7270834 For use in the treatment of several diseases such as diseases of the feet in animals, such as the hooves in horses, arthritis, muscular affections, etc. in human beings
09/18/2007US7270832 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc.
09/18/2007US7270831 Orally administrable opioid formulations having extended duration of effect
09/18/2007US7270830 Transdermal buprenorphine dosage regimen for analgesia
09/18/2007US7270802 Non-lethal temporary incapacitation formulation and novel solvent system
09/18/2007US7270440 Make-up applicator with LED light source
09/18/2007CA2414680C Methods for treating inflammation-mediated conditions of the eye
09/18/2007CA2413624C Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
09/18/2007CA2392473C Bioadhesive drug delivery system
09/18/2007CA2388325C Ciclesonide-containing aqueous pharmaceutical composition
09/18/2007CA2388322C Ciclesonide contained pharmaceutical composition for application to mucosa
09/18/2007CA2338859C Estradiol-containing patch for transdermal administration of hormones
09/18/2007CA2323809C A method for chemoprevention of prostate cancer
09/18/2007CA2319609C Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
09/18/2007CA2304662C Methods for fabricating polymer-based controlled release preparations
09/18/2007CA2297832C Pellet-type formulation intended for treating the intestinal tract
09/18/2007CA2282513C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
09/18/2007CA2259581C Plasters for percutaneous absorption
09/18/2007CA2248179C .beta.-lactam antibiotic-containing tablet and production thereof
09/18/2007CA2216919C Nanospheres comprising a biocompatible polysaccharide
09/18/2007CA2184733C Spin encapsulation apparatus and method of use
09/18/2007CA2168656C A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
09/18/2007CA2164193C Intravaginal preparation containing physiologically active peptide
09/13/2007WO2007103960A1 Ocular therapy using sirtuin-activating agents
09/13/2007WO2007103931A2 Nanofluidized b-12 composition and process for treating pernicious anemia
09/13/2007WO2007103557A2 Coating capsules with active pharmaceutical ingredients
09/13/2007WO2007103534A2 Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof
09/13/2007WO2007103511A1 Multi-layer medical patch with impermeable center
09/13/2007WO2007103453A1 Ezetimibe compositions
09/13/2007WO2007103294A2 Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
09/13/2007WO2007103293A2 Ethanol-resistant sustained release formulations
09/13/2007WO2007103200A2 Oral controlled release formulation for sedative and hypnotic agents
09/13/2007WO2007103190A2 Transdermal treatment of tendinop athy using no donor
09/13/2007WO2007103186A2 Method and apparatus for the preparation of capsules
09/13/2007WO2007103113A2 Dosage forms for administering combinations of drugs
09/13/2007WO2007102817A1 Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
09/13/2007WO2007102714A1 Safe controlled release preparation composition containing zolpidem or its salt
09/13/2007WO2007102481A1 Vector for nuclear transport of substance
09/13/2007WO2007102447A1 Adhesive microcapsule
09/13/2007WO2007102439A1 Fractionation product of aqueous extract of eucommia ulmoides oliver leaf, and composition for oral ingestion comprising the fractionation product
09/13/2007WO2007102242A1 External pharmaceutical composition
09/13/2007WO2007102169A1 Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
09/13/2007WO2007102082A1 High oxazolidinone content solid dosage forms
09/13/2007WO2007101660A1 Plaster packaging
09/13/2007WO2007101659A1 Easy-to-handle plaster containing an active substance
09/13/2007WO2007101560A1 Medicament formulations comprising fluoroquinolones
09/13/2007WO2007101400A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
09/13/2007WO2007084247A9 Stable therapeutic formulations
09/13/2007WO2007080117A3 Phyllosilicate formulations for the controlled release of active substances
09/13/2007WO2007073702A3 Multi-layered tablet with triple release combination
09/13/2007WO2007071915A3 Pharmaceutical product comprising porous silicon
09/13/2007WO2007068403A3 Remineralizing products
09/13/2007WO2007065625A3 Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations
09/13/2007WO2007060170A3 Bilayer tablet comprising telmisartan and diuretic
09/13/2007WO2007049278A3 A method for preparing liposomes and uses thereof
09/13/2007WO2007036809A3 Novel acetylsalicylic acid formulations
09/13/2007WO2007031883A3 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
09/13/2007WO2007022090A3 Topical delivery with a carrier fluid
09/13/2007WO2007010508A3 Controlled release compositions of metaxalone
09/13/2007WO2006138330A3 Tissue treatment methods
09/13/2007WO2006085896A3 Self assembled nanotubes and methods for preparing the same
09/13/2007WO2005115354A3 Compositions and methods for bone formation and remodeling
09/13/2007WO2004103416A3 Fluid absorbing adhesive paste
09/13/2007US20070213658 Drug delivery in association with medical or surgical procedures
09/13/2007US20070213411 Dispersions And Methods Of Preparing Them
09/13/2007US20070213406 Anti-Inflammatory Analgesic External Aqueus Liquid Preparation
09/13/2007US20070213393 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
09/13/2007US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
09/13/2007US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213261 Asthma Preparation
09/13/2007US20070213234 Oil-in-water emulsion for delivery
09/13/2007US20070212431 Cream for treatment of skin injured by the sun
09/13/2007US20070212422 Dry powder for inhalation
09/13/2007US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof